February/March 2009, Vol 2, No 2

Regulatory

What Changes Can Your Health Plan Expect from the New Administration?
Interview with Dan Mendelson
Stakeholder Perspective by Joseph R. Antos, PhD

Business

Patient Cost-Sharing on the Rise: Results from the Benefit Design Index
Melinda C. Haren, RN
; Kirk McConnell
Stakeholder Perspective by David Williams
Employer-Based Health Initiative: Impact on Employees? Cardiovascular Outcomes
Gene Reeder, RPh, PhD
; Christine H. Divers, PhD
; Del Deem
; Becky J. Cherney
; Gaye Fortner, RN, BSN, MSN
; Louise Y. Probst
Stakeholder Perspective by Charles E. Collins, Jr, MS, MBA

Clinical

Methicillin-Resistant Staphylococcus aureus: A Growing Risk in the Hospital and in the Community
Jose L. Raygada, MD
; Donald P. Levine, MD
Stakeholder Perspective by Dennis M. Perrotta, PhD, CIC

Generic Drug Trends

Will 2009 Usher in the Era of Biogenerics?
Dalia Buffery, MA, ABD

Commentary

FDA WATCH
Wayne Kuznar
; Nirav R. Shah, MD, MPH
; F. Randy Vogenberg, RPh, PhD